HCPLive Network
Latest Oncology Headlines
Thursday, January 29, 2015
Teledermoscopy is feasible and effective for short-term monitoring of clinically atypical nevi, according to a study published online Jan. 28 in JAMA Dermatology.
Thursday, January 29, 2015
Phosphodiesterase type 5 inhibitor use after radical prostatectomy is associated with increased risk of biochemical recurrence, according to a study published in the February issue of The Journal of Urology.
Thursday, January 29, 2015
By Andrew J. Roth
The FDA has expanded the approval of ibrutinib (Imbruvica) for the treatment of patients with Waldenström’s macroglobulinemia (WM), according to a press release.
Thursday, January 29, 2015
By Laura Martin
An increased understanding of tumor immunology has led to seven new melanoma drug approvals since 2011, including the recent approvals of the PD-1 inhibitors nivolumab (Opdivo) and pembrolizumab (Keytruda).
Thursday, January 29, 2015
By Andrew J. Roth
The combination of trametinib (Mekinist) and dabrafenib (Tafinlar) improved overall survival (OS) compared with vemurafenib alone in patients with unresectable (stage IIIC) or metastatic (stage IV) BRAFV600E/K mutation-positive cutaneous melanoma.
Thursday, January 29, 2015
By Silas Inman
A supplemental New Drug Application has been submitted to the FDA for the full regulatory approval of carfilzomib as a treatment for patients with relapsed multiple myeloma.
Thursday, January 29, 2015
By Jason M. Broderick
For additional insight on the published RESPONSE data and the use of ruxolitnib to treat polycythemia vera, we reached out to Richard Levy, MD, executive vice president and chief drug development and medical officer at Incyte, the company that co-manufactures ruxolitinib with Novartis.
Wednesday, January 28, 2015
By Renato G Martins, MD, MPH
Ten or 15 years ago, a diagnosis of advanced non– small cell lung cancer (NSCLC) led directly to a discussion of chemotherapy.
Wednesday, January 28, 2015
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah recently discovered the mechanism potentially triggering pancreatic cancer from the defects resulting from extrusion, the process through which cells are squeezed out of overcrowded tissue to die.
Wednesday, January 28, 2015
Current smoking reduces odds of survival in prostate cancer, according to a new study published online Jan. 27 in BJU International.
Wednesday, January 28, 2015
Core needle biopsy is a more sensitive tool than fine-needle aspiration cytology for cervical lymphadenopathy evaluation, according to a study published in the February issue of Head & Neck.
Wednesday, January 28, 2015
For women undergoing screening mammography, there has been an increase in the percentage of biopsies with diagnoses of invasive carcinoma and ductal carcinoma in situ, according to a study published online Jan. 20 in Cancer.
Wednesday, January 28, 2015
By Aaron S. Mansfield MD, Tobias Peikert, MD
Malignant pleural mesothelioma (MPM) is an inexorably progressive and almost universally fatal malignancy.
Wednesday, January 28, 2015
Prostate biopsies that combine magnetic resonance imaging technology with ultrasound appear to give men better information regarding the seriousness of their cancer, according to a new study published in the Jan. 27 issue of the Journal of the American Medical Association.
Wednesday, January 28, 2015
Many women with breast cancer lack basic knowledge about their disease, such as their cancer stage and other characteristics, according to a study published online Jan. 26 in Cancer.
Tuesday, January 27, 2015
Coping with challenges is part of the human condition, but self-awareness can have far-reaching results. Just ask Edith A. Perez, MD, about her experience attending medical school.
Tuesday, January 27, 2015
By By Keith A. Delman, MD and Viraj Master, MD, PhD
Surgical intervention is a Machiavellian endeavor: the ends justify the means. This obligates the clinician to minimize the risk of a procedure to justify the gains obtained from an intervention.
Tuesday, January 27, 2015
By Jeannette Y. Wick, RPh, MBA, FASCP
In March 2014, the Society of Surgical Oncology Susan G. Komen for the Cure Symposium focused on the literature on the epidemiology, molecular pathology, and therapy considerations of triple-negative breast cancer. The Annals of Surgical Oncology has published a summary of this work ahead of print.
Monday, January 26, 2015
By Rachel Lutz
Researchers from the University of Massachusetts Amherst will investigate if a blood test can predict breast cancer.
Monday, January 26, 2015
By Andrew J. Roth
To gain insight into the unanswered questions surrounding the treatment of pNETs, OncLive interviewed Pamela L. Kunz, MD, Assistant Professor of Medicine/Oncology at Stanford University.
Physician's Money Digest
Medical patients sometimes hear what we say skeptically, but Americans in general will believe any darn thing.
Some brokerages receive "order flow payments" in exchange for routing trades to certain exchanges. This practice is a major money-maker for brokers, but some worry it comes at the expense of clients.